This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
3 Apr 2019

PuroMill Resins featured in Pharma Intelligence CPHI North America Preview Edition

Purolite, a wear-resistent bead-form polymeric media has a Drug Master File register with the U.S. FDA and is manufactured in an FDA inspected, cGMP certified facility.

Purolite's novel polymeric milling media was featured in the Pharma intelligence CPhi North America Preview published by Informa.

The article describes the physical characteristics of the media that makes it perform better than traditional media (such as YTZ) for creating nanoparticles in wet milling drug formulation processes.

The media enables the creation of pure drug nanoparticles <100 nm, which can enhance drug solubility for compounds with poor aqueous solubility.

PuroMill polymeric milling media can be used for small-molecule compounds for oral, parental, ocular, inhalable and other dosage forms to help improve solubility.